Seminar series in U.S.

Translational Pharmaceutics and the Benefits of Real-Time Adaptive Manufacturing

Our facilities

Quotient Sciences operates from state-of-the-art manufacturing and clinical facilities in the U.S. and U.K.

Our facilities include two clinical pharmacology units, two purpose-built pharmaceutical development and manufacturing sites. We support you by working under FDA or MHRA guidelines and offer a full range of support services, from study setup through to data analysis and reporting.

Global formulation and manufacturing

  • Pharmaceutical development and manufacturing facilities in the U.S. and U.K.
  • Production of Phase I – Phase III clinical drug supplies
  • Commercial product manufacture for solid dosage forms and liquid formats
  • U.S. facility is FDA / EMA / PMDA approved, U.K. facility is MHRA approved
  • GMP manufacturing suites globally including high potent compound handling
  • Scalable manufacturing equipment for non-sterile dosage forms
  • Batch sizes ranging from small scale (200g) to large scale (500kg) for tablet and capsule drug products and up to 350L for liquid presentations
  • Clinical packaging, labeling and global distribution for Phase I – Phase IIb programs

Global clinical pharmacology

  • Two purpose built Phase I units in the U.S. (Miami) and U.K. (Nottingham)
  • >245 bed capacity across Miami (U.S.), and Nottingham (U.K.)
  • Experienced team of 16 physicians and principal investigators
  • >1,300 Phase I studies completed to date
  • Database of >25,000 active participants across a broad demographic
  • Medical writing, data management, pharmacokinetics, statistical analysis and reporting

Contact

Get in touch with us

Ready to get started?

Contact us

Ask us a question